Ownership history in UBS Group AG · 40 quarters on record
This page tracks every 13F SEC filing in which UBS Group AG reported a position in PROPHASE LABS INC (PRPH). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 3,056 | -16,684 | -84.5% | 0.00% | $1K | $0.45 |
| 2025 Q3 | REDUCED | 19,740 | -37,930 | -65.8% | 0.00% | $9K | $4.60 |
| 2025 Q2 | ADDED | 57,670 | +48,575 | +534.1% | 0.00% | $23K | $3.90 |
| 2025 Q1 | ADDED | 9,095 | +5,866 | +181.7% | 0.00% | $4K | $4.00 |
| 2024 Q4 | REDUCED | 3,229 | -7,279 | -69.3% | 0.00% | $2K | $7.60 |
| 2024 Q3 | ADDED | 10,508 | +7,185 | +216.2% | 0.00% | $25K | $24.20 |
| 2024 Q1 | REDUCED | 3,323 | -1,425 | -30.0% | 0.00% | $22K | $64.70 |
| 2023 Q1 | REDUCED | 4,748 | -11,793 | -71.3% | 0.00% | $36K | $76.20 |
| 2022 Q4 | REDUCED | 16,541 | -8,920 | -35.0% | 0.00% | $159K | $96.30 |
| 2022 Q3 | ADDED | 25,461 | +24,024 | +1671.8% | 0.00% | $287K | $112.80 |
As of 2025 Q4 — sorted by position size